Omnicell completes $172.5 million 1.00% convertible notes offering due 2029
Omnicell completed a private offering of $172.5 million of 1.00% convertible senior notes due December 1, 2029 on November 22, 2024, including the full exercise of a $22.5 million option. The company used about $391.2 million in cash, together with net proceeds of about $166.0 million, to repurchase $400.0 million of its 0.25% convertible notes due 2025. The filing shows a refinancing of near-term convertible debt with longer-dated debt, with potential dilution to shareholders if the notes convert into stock.
Key points
- Offering totaled $172.5 million, including $22.5 million from the initial purchasers' option, and closed November 22, 2024.
- Notes bear 1.00% annual interest and mature December 1, 2029; the initial conversion price is about $57.25 per share, a premium of about 35% to the November 19, 2024 closing price.
- Net proceeds were about $166.0 million; about $391.2 million in cash was used to repurchase $400.0 million of 2025 notes.
- The company may not redeem the notes before December 6, 2027.
The filing
Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 25, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.